Argenx
ARGX
#456
Rank
ยฃ38.00 B
Marketcap
ยฃ614.14
Share price
-0.85%
Change (1 day)
14.80%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2025 : ยฃ4.45 Billion

According to Argenx 's latest financial reports the company has ยฃ4.45 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2019 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ4.38 B36.23%
2023-12-31$ยฃ3.21 B38.29%
2022-12-31$ยฃ2.32 B23.88%
2021-12-31$ยฃ1.87 B52.87%
2020-12-31$ยฃ1.22 B36.43%
2019-12-31$ยฃ0.90 B62.18%
2018-12-31$ยฃ0.55 B51.08%
2017-12-31$ยฃ0.36 B546.61%
2016-12-31$ยฃ56.81 M88.94%
2015-12-31$ยฃ30.07 M-36.79%
2014-12-31$ยฃ47.57 M89.59%
2013-12-31$ยฃ25.09 M84.13%
2012-12-31$ยฃ13.62 M-41.54%
2011-12-31$ยฃ23.3 M164.38%
2010-12-31$ยฃ8.81 M